NO20052813L - Celecoxib-promedikament - Google Patents

Celecoxib-promedikament

Info

Publication number
NO20052813L
NO20052813L NO20052813A NO20052813A NO20052813L NO 20052813 L NO20052813 L NO 20052813L NO 20052813 A NO20052813 A NO 20052813A NO 20052813 A NO20052813 A NO 20052813A NO 20052813 L NO20052813 L NO 20052813L
Authority
NO
Norway
Prior art keywords
celecoxib
prodrug
propanamide
pyrazol
methylphenyl
Prior art date
Application number
NO20052813A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052813D0 (no
Inventor
Matthew J Graneto
Gary D Ewing
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20052813D0 publication Critical patent/NO20052813D0/no
Publication of NO20052813L publication Critical patent/NO20052813L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
NO20052813A 2002-11-12 2005-06-10 Celecoxib-promedikament NO20052813L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42570302P 2002-11-12 2002-11-12
PCT/US2003/035222 WO2004043934A1 (en) 2002-11-12 2003-11-03 Celecoxib prodrug

Publications (2)

Publication Number Publication Date
NO20052813D0 NO20052813D0 (no) 2005-06-10
NO20052813L true NO20052813L (no) 2005-08-02

Family

ID=32313040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052813A NO20052813L (no) 2002-11-12 2005-06-10 Celecoxib-promedikament

Country Status (17)

Country Link
US (1) US20040092566A1 (ko)
EP (1) EP1562910A1 (ko)
JP (1) JP2006508123A (ko)
KR (1) KR20050072823A (ko)
CN (1) CN1711247A (ko)
AR (1) AR042037A1 (ko)
AU (1) AU2003291278A1 (ko)
BR (1) BR0316155A (ko)
CA (1) CA2505635A1 (ko)
CO (1) CO5700738A2 (ko)
MX (1) MXPA05004991A (ko)
NO (1) NO20052813L (ko)
PL (1) PL376918A1 (ko)
RU (1) RU2005114398A (ko)
TW (1) TW200424179A (ko)
WO (1) WO2004043934A1 (ko)
ZA (1) ZA200503188B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303591A1 (en) * 2002-12-30 2004-07-29 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
WO2006055381A2 (en) * 2004-11-16 2006-05-26 Merck & Co., Inc. Prodrugs of (2r)-2-propyloctanoic acid for treatment of stroke
CN101805290A (zh) * 2010-04-01 2010-08-18 中国人民解放军第四军医大学 氨基磺酰吡唑类化合物及其用途
BRPI1003050B1 (pt) * 2010-08-04 2021-05-25 Universidade Federal De Minas Gerais Compostos derivados do ácido araquidônico substituídos com análogos de coxibes para tratamento de dor
KR101245078B1 (ko) * 2010-11-11 2013-03-18 부산대학교 산학협력단 대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
US9562015B2 (en) 2011-11-17 2017-02-07 The Regents Of The University Of Colorado, A Body Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
CN104892514A (zh) * 2015-05-19 2015-09-09 广州诺威生物技术有限公司 一种咪唑类新化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69719496T2 (de) * 1996-04-12 2004-04-08 G.D. Searle & Co., Chicago N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULPHONYLPROPYLAMID und sein NATRIUMSALZ ALS PRO-PHARMAKON VON COX-2 INHIBITOREN

Also Published As

Publication number Publication date
RU2005114398A (ru) 2006-01-20
AU2003291278A1 (en) 2004-06-03
TW200424179A (en) 2004-11-16
PL376918A1 (pl) 2006-01-09
WO2004043934A1 (en) 2004-05-27
MXPA05004991A (es) 2005-08-02
CA2505635A1 (en) 2004-05-27
AR042037A1 (es) 2005-06-08
KR20050072823A (ko) 2005-07-12
BR0316155A (pt) 2005-09-27
NO20052813D0 (no) 2005-06-10
ZA200503188B (en) 2006-11-29
JP2006508123A (ja) 2006-03-09
CN1711247A (zh) 2005-12-21
CO5700738A2 (es) 2006-11-30
US20040092566A1 (en) 2004-05-13
EP1562910A1 (en) 2005-08-17

Similar Documents

Publication Publication Date Title
NO20052813L (no) Celecoxib-promedikament
NO20053215D0 (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
MA28739B1 (fr) Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer
DK1532145T3 (da) Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3
DK3724191T3 (da) 5-(2-(2,5-difluorphenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazol[1,5-a]pyrimidinderivater og lignende forbindelser som trk-kinasehæmmere til cancerbehandling
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
DK1756064T3 (da) Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder
NO20091299L (no) Substituerte sulfonamidderivater
NO20033608D0 (no) 3-(4-amidopyrrol-2-ylmetliden)-2-indolinonderivater som protein kinase inhibitorer
NO20053201L (no) Nye heterocykliske fluorglukosidderivater, legemidler inneholdende disse forbindelser og deres anvendelse.
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
DK1318992T3 (da) Imidazolderivater som Raf-kinaseinhibitorer
EA200970161A1 (ru) Производные 1-(-d-гликопиранозил)-3-(4-циклопропилфенилметил)-4-галогеноиндола и их применение в качестве ингибиторов sglt
NL350053I2 (nl) Bixafen
NO20054244D0 (no) Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel
NO20063621L (no) Derivater av N-`(1,5-difenyl-1H-pyrazol-3-yl) sulfonamid med CB1 receptoraffinitet
NO20014986L (no) 4,5-diaryl-3(2H)-furanonderivater som cyklooksygenase-2- inhibitorer
NO20070067L (no) Pyrrolopyridinderivater
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
DK1423384T3 (da) Pyridinderivater som Raf kinaseinhibitorer
NO20064603L (no) Anvendelse av antagonister av CBI-reseptoren av preparat anvendelig for behandling av leversykdommer.
DK2094699T3 (da) Hidtil ukendte imidazolonderivater, fremstilling deraf som lægemidler, farmaceutiske præparater og anvendelse deraf som hæmmere af proteinkinaser, især cdc7
NO20062442L (no) Analgesiske suspensjoner md kontrollert frigivelse
NO20064986L (no) Krystallin Pyrazolderivater
CR10429A (es) Suspension acuosa estable